Literature DB >> 9049792

Monocytic TNF alpha secretion patterns in IDDM patients with periodontal diseases.

G E Salvi1, J G Collins, B Yalda, R R Arnold, N P Lang, S Offenbacher.   

Abstract

The aim of the present study was to identify whether monocytic TNF alpha secretion patterns could serve as a potential phenotypic discriminator for periodontal disease susceptibility within insulin-dependent diabetes mellitus (IDDM) patients. In 32 IDDM individuals the lipopolysaccharide (LPS) stimulated monocytic TNF alpha secretion dose-response characteristics were analyzed and related to two different periodontal status categories. Diabetics were divided into group A (gingivitis or mild periodontal disease) and group B (moderate to severe periodontal disease). In addition, 17 non-diabetic individuals with various degrees of periodontal disease served as control patients. Diabetics as a group had a significantly higher monocytic TNF alpha production in response to increasing Porphyromonas gingivalis A 7436 lipopolysaccharide concentrations (0, 0.003, 0.03, 0.3 and 3.0 micrograms/ml) as compared to non-diabetic patients with gingivitis or adult periodontitis (p < 0.05). A significant difference in the dose response was also noted in the level of TNF alpha secreted as a function of P. gingivalis LPS concentrations between group A and B diabetics, as determined by two-way repeated measurements ANOVA (p < 0.05). Furthermore, there was no significant difference in the mean HbA1C between the two diabetic groups, and the TNF alpha level was not significantly associated with the HbA1C level within diabetic patients. These data suggest that the diabetic state results in an upregulated monocytic TNF alpha secretion phenotype (4.6-fold increase) which, in the presence of Gram-negative bacterial challenge, is associated with a more severe periodontal disease expression. In addition, approximately 40% (10 of 24) IDDM periodontitis patients in group B demonstrated a 62-fold elevation in TNF alpha secretion relative to non-diabetic gingivitis or periodontitis patients and a 13.5-fold increase relative to IDDM group A (gingivitis or mild periodontitis) patients.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9049792     DOI: 10.1111/j.1600-051x.1997.tb01178.x

Source DB:  PubMed          Journal:  J Clin Periodontol        ISSN: 0303-6979            Impact factor:   8.728


  36 in total

1.  Impaired inflammatory responses to multiple toll-like receptor ligands in alveolar macrophages of streptozotocin-induced diabetic mice.

Authors:  Hideaki Yamasawa; Masayuki Nakayama; Masashi Bando; Yukihiko Sugiyama
Journal:  Inflamm Res       Date:  2012-01-07       Impact factor: 4.575

2.  Diabetes enhances periodontal bone loss through enhanced resorption and diminished bone formation.

Authors:  R Liu; H S Bal; T Desta; N Krothapalli; M Alyassi; Q Luan; D T Graves
Journal:  J Dent Res       Date:  2006-06       Impact factor: 6.116

Review 3.  Diabetes mellitus and periodontal diseases.

Authors:  Corneliu Sima; Michael Glogauer
Journal:  Curr Diab Rep       Date:  2013-06       Impact factor: 4.810

4.  Blockade of RAGE suppresses periodontitis-associated bone loss in diabetic mice.

Authors:  E Lalla; I B Lamster; M Feit; L Huang; A Spessot; W Qu; T Kislinger; Y Lu; D M Stern; A M Schmidt
Journal:  J Clin Invest       Date:  2000-04       Impact factor: 14.808

5.  Loss of interleukin-10 exacerbates early Type-1 diabetes-induced bone loss.

Authors:  Naiomy D Rios-Arce; Andrew Dagenais; Derrick Feenstra; Brandon Coughlin; Ho Jun Kang; Susanne Mohr; Laura R McCabe; Narayanan Parameswaran
Journal:  J Cell Physiol       Date:  2019-09-19       Impact factor: 6.384

Review 6.  Diabetes and periodontal disease: a two-way relationship.

Authors:  L Casanova; F J Hughes; P M Preshaw
Journal:  Br Dent J       Date:  2014-10       Impact factor: 1.626

Review 7.  Diabetes mellitus and periodontitis: a tale of two common interrelated diseases.

Authors:  Evanthia Lalla; Panos N Papapanou
Journal:  Nat Rev Endocrinol       Date:  2011-06-28       Impact factor: 43.330

8.  Tumor necrosis factor-alpha mediates diabetes-enhanced apoptosis of matrix-producing cells and impairs diabetic healing.

Authors:  Rongkun Liu; Harbinder S Bal; Tesfahun Desta; Yugal Behl; Dana T Graves
Journal:  Am J Pathol       Date:  2006-03       Impact factor: 4.307

Review 9.  Rehabilitative considerations for dental implants in the diabetic patient.

Authors:  Preeti Agarwal Katyayan; Manish Katyayan; Rupal J Shah
Journal:  J Indian Prosthodont Soc       Date:  2012-11-01

Review 10.  Diabetic complications and dysregulated innate immunity.

Authors:  Dana T Graves; Rayyan A Kayal
Journal:  Front Biosci       Date:  2008-01-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.